Redmile Group

Redmile as of June 30, 2012

Portfolio Holdings for Redmile

Redmile holds 40 positions in its portfolio as reported in the June 2012 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Ariad Pharmaceuticals 7.6 $24M 1.4M 17.21
Gilead Sciences (GILD) 7.3 $23M 442k 51.28
Dynavax Technologies Corporation 6.9 $21M 4.9M 4.32
Onyx Pharmaceuticals 6.8 $21M 315k 66.45
Zimmer Holdings (ZBH) 6.4 $20M 307k 64.36
Stryker Corporation (SYK) 6.0 $19M 337k 55.10
Grifols S A 5.5 $17M 1.8M 9.60
Medivation 4.4 $14M 150k 91.40
Amarin Corporation (AMRN) 4.2 $13M 902k 14.46
ArthroCare Corporation 3.3 $10M 347k 29.28
Celgene Corporation 3.2 $10M 155k 64.16
Nektar Therapeutics (NKTR) 3.1 $9.6M 1.2M 8.07
Ym Biosciences 3.0 $9.3M 4.7M 1.98
Orthofix International Nv Com Stk 2.5 $7.9M 191k 41.25
NuVasive 2.5 $7.6M 300k 25.36
Amicus Therapeutics (FOLD) 2.4 $7.5M 1.4M 5.50
Conceptus 2.4 $7.4M 373k 19.82
AstraZeneca (AZN) 2.3 $7.0M 156k 44.75
Trius Therapeutics 2.0 $6.3M 1.1M 5.76
BioSpecifics Technologies 1.9 $5.8M 311k 18.78
Hca Holdings (HCA) 1.9 $5.8M 190k 30.43
Cutera (CUTR) 1.8 $5.4M 751k 7.19
Health Management Associates 1.7 $5.3M 680k 7.85
Array BioPharma 1.6 $4.9M 1.4M 3.47
Align Technology (ALGN) 1.5 $4.6M 139k 33.46
Vanguard Health Systems 1.4 $4.4M 490k 8.89
HeartWare International 1.1 $3.3M 37k 88.79
Neurocrine Biosciences (NBIX) 0.9 $2.9M 368k 7.91
Clovis Oncology 0.9 $2.8M 130k 21.68
Cyclacel Pharmaceuticals 0.8 $2.5M 5.3M 0.46
Vivus 0.8 $2.4M 85k 28.53
TranS1 (TSON) 0.7 $2.3M 925k 2.48
MAKO Surgical 0.6 $1.7M 68k 25.60
Medicines Company 0.1 $266k 12k 22.93
Incyte Corporation (INCY) 0.1 $250k 11k 22.69
Hologic (HOLX) 0.1 $180k 10k 18.00
Elan Corporation 0.1 $182k 13k 14.56
Qlt 0.1 $148k 19k 7.63
PharMerica Corporation 0.0 $109k 10k 10.90
Harvard Bioscience (HBIO) 0.0 $94k 25k 3.76